Show simple item record

dc.contributor.authorTalesh, KT
dc.contributor.authorMotamedi, MHK
dc.contributor.authorKahnamouii, S
dc.date.accessioned2018-08-26T08:50:59Z
dc.date.available2018-08-26T08:50:59Z
dc.date.issued2011
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53170
dc.description.abstractPurpose: The purpose of this study was to compare the efficacy of ondansetron and metoclopramide, administered for the prophylaxis of vomiting in patients undergoing oral and maxillofacial surgery under general anesthesia. Methods: One hundred patients undergoing mandibular osteotomy surgery were studied. Patients were allocated randomly to receive 1 of 2 treatment regimens: 0.15 mg/kg ondansetron or 0.5 mg/kg metoclopramide intravenously 30 minutes before extubation. All were adults and were treated by one surgeon and all operations were the same and lasted 2.5 to 3.0 hours. The patients were assessed at 3 time periods: 0 to 3 hours, 3 to 12 hours, and 12 to 24 hours postoperatively for emesis. Result: The data from this study showed that during the first 24-hour postoperative period, patients receiving ondansetron following general anesthesia had an 11% (11 patients) incidence of emesis compared with 28% (22 patients) in the group that received metoclopramide. Conclusion: In this study, ondansetron (0.1 mg/kg) was twice as effective in preventing postoperative vomiting compared with metoclopramide. آ© 2011 Mosby, Inc.
dc.language.isoEnglish
dc.relation.ispartofOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
dc.subjectantiemetic agent
dc.subjectmetoclopramide
dc.subjectondansetron
dc.subjectadult
dc.subjectarticle
dc.subjectartificial ventilation
dc.subjectclinical trial
dc.subjectcomparative study
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectendotracheal intubation
dc.subjectfollow up
dc.subjecthuman
dc.subjectinhalation anesthesia
dc.subjectintravenous drug administration
dc.subjectmandible
dc.subjectosteotomy
dc.subjectpostoperative nausea and vomiting
dc.subjectpremedication
dc.subjectrandomized controlled trial
dc.subjecttime
dc.subjecttreatment outcome
dc.subjectAdult
dc.subjectAnesthesia, Inhalation
dc.subjectAntiemetics
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectInjections, Intravenous
dc.subjectIntubation, Intratracheal
dc.subjectMandible
dc.subjectMetoclopramide
dc.subjectOndansetron
dc.subjectOsteotomy
dc.subjectPostoperative Nausea and Vomiting
dc.subjectPremedication
dc.subjectRespiration, Artificial
dc.subjectTime Factors
dc.subjectTreatment Outcome
dc.titleComparison of ondansetron and metoclopramide antiemetic prophylaxis in maxillofacial surgery patients
dc.typeArticle
dc.citation.volume111
dc.citation.issue3
dc.citation.spage275
dc.citation.epage277
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/j.tripleo.2010.04.034


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record